Late lumen loss and intima hyperplasia after sirolimus-eluting and zotarolimus-eluting stent implantation in diabetic patients: the diabetes and drug-eluting stent (DiabeDES III) angiography and intravascular ultrasound trial

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

Patients with diabetes mellitus have increased risk of in-stent restenosis after coronary stent implantation due to neointimal hyperplasia (NIH). The aim of this study was to use quantitative coronary angiography (QCA) and volumetric intravascular ultrasound (IVUS) to evaluate the effects of the sirolimus-eluting Cypher® stent (SES) and the zotarolimus-eluting Endeavor® stent (ZES) on angiographic late lumen loss and intima hyperplasia in diabetic patients.
Original languageEnglish
Pages (from-to)323-31
Number of pages9
Publication statusPublished - 2011

    Research areas

  • Aged, Angioplasty, Balloon, Laser-Assisted, Coronary Angiography, Coronary Artery Disease, Coronary Restenosis, Diabetes Complications, Drug-Eluting Stents, Female, Follow-Up Studies, Humans, Hyperplasia, Male, Middle Aged, Neointima, Risk Factors, Single-Blind Method, Sirolimus, Treatment Outcome, Ultrasonography, Interventional

See relations at Aarhus University Citationformats

ID: 43884243